Spyre Therapeutics, Inc. (SYRE)
65.60
+14.32
(+27.91%)
USD |
NASDAQ |
Apr 13, 14:36
Spyre Therapeutics Market Cap : 5.153B for April 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Tyra Biosciences, Inc. | 1.922B |
| Savara, Inc. | 1.219B |
| Agios Pharmaceuticals, Inc. | 1.936B |
| Tandem Diabetes Care, Inc. | 1.362B |
| ACADIA Pharmaceuticals, Inc. | 3.594B |
Market Cap Related Metrics
| Price to Book Value | 9.211 |
| Price | 65.60 |
| Earnings Yield | -3.17% |